Pharma Research News
Global and Indian pharma research, drug discovery, clinical-trial and biotech R&D coverage from public media feeds.
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs - WSJ
AstraZeneca to Invest $2 Billion in Summit Therapeutics, Collaborate on Cancer Drugs WSJ…
Biodeal Pharmaceuticals acquires Biological E facility, expands into sterile injectables - Express Pharma
Biodeal Pharmaceuticals acquires Biological E facility, expands into sterile injectables Express Pharma…
Drug patents in India: How they work and when govt can override them - Business Standard
Drug patents in India: How they work and when govt can override them Business Standard…
Specialty drug distribution platform MrMed speeds up growth, plans fundraise - VCCircle
Specialty drug distribution platform MrMed speeds up growth, plans fundraise VCCircle…
India is the hub of our R&D strength, process innovation and regulatory excellence - Express Pharma
India is the hub of our R&D strength, process innovation and regulatory excellence Express Pharma…
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial - Nature
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial Nature…
Promising therapy for fatty liver disease reduces fat, inflammation, and scarring in preclinical models - Medical Xpress
Promising therapy for fatty liver disease reduces fat, inflammation, and scarring in preclinical models Medical Xpress…
MDU signs pact with pharma firms to boost training, research opportunities - The Times of India
MDU signs pact with pharma firms to boost training, research opportunities The Times of India…
UniQure tumbles with latest data for Huntington’s gene therapy - biopharmadive.com
UniQure tumbles with latest data for Huntington’s gene therapy biopharmadive.com…
Epilepsy R&D is breaking out of its old playbook - PharmaVoice
Epilepsy R&D is breaking out of its old playbook PharmaVoice…
UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 years - BioSpace
UniQure crashes as Huntington’s gene therapy shows less slowing of disease at 4 years BioSpace…
Kerala HC Asks Centre to Assess Cancer Drug Ribociclib's Affordability Before Patent Use Decision - Medical Dialogues
Kerala HC Asks Centre to Assess Cancer Drug Ribociclib's Affordability Before Patent Use Decision Medical Dialogues…
uniQure stock crashes as Huntington’s gene therapy data weaken - fiercebiotech.com
uniQure stock crashes as Huntington’s gene therapy data weaken fiercebiotech.com…
Summit Therapeutics and AstraZeneca Enter $2B Strategic Investment and Oncology Collaboration - PharmaShots
Summit Therapeutics and AstraZeneca Enter $2B Strategic Investment and Oncology Collaboration PharmaShots…
UniQure’s gene therapy continues to slow Huntington’s progression after four years - STAT
UniQure’s gene therapy continues to slow Huntington’s progression after four years STAT…
Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve - livemint.com
Rare diseases can be treated with tailored gene therapy but India’s regulatory system must evolve livemint.com…
Kodiak’s stock rallies on Phase III wAMD success - Clinical Trials Arena
Kodiak’s stock rallies on Phase III wAMD success Clinical Trials Arena…
Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms - STAT
Drug pricing, Medicaid, and research funding: The key policy issues at stake in the midterms STAT…
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui - fiercebiotech.com
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui fiercebiotech.com…
Kodiak skyrockets on positive study data for 2 eye drugs - biopharmadive.com
Kodiak skyrockets on positive study data for 2 eye drugs biopharmadive.com…
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor - BioSpace
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor BioSpace…
Roche Halts Development of Obesity Drug Candidate - WSJ
Roche Halts Development of Obesity Drug Candidate WSJ…
Kodiak's stock doubles as resurrected eye disease drug matches Eylea in phase 3 - fiercebiotech.com
Kodiak's stock doubles as resurrected eye disease drug matches Eylea in phase 3 fiercebiotech.com…
Research makes strong case for broader use of GLP1 drugs to protect hearts - News-Medical
Research makes strong case for broader use of GLP1 drugs to protect hearts News-Medical…
Sugar molecule in red meat linked to higher risk of developing type 2 diabetes - Medical Xpress
Sugar molecule in red meat linked to higher risk of developing type 2 diabetes Medical Xpress…
What’s The Latest On CRISPR Gene Editing Technology? - Forbes
What’s The Latest On CRISPR Gene Editing Technology? Forbes…
Hidden E. coli survive in bladder cells, but existing drug helps antibiotics reach them in lab tests - Medical Xpress
Hidden E. coli survive in bladder cells, but existing drug helps antibiotics reach them in lab tests Medical Xpress…
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says - Reuters
Eli Lilly owes Nektar $90 mln in drug collaboration dispute, US jury says Reuters…
FDA commissioner nominee affirms MMR vaccine safety despite Trump’s claims - Pharmaceutical Technology
FDA commissioner nominee affirms MMR vaccine safety despite Trump’s claims Pharmaceutical Technology…
MPSC Drug Inspector Exam Leak: 2 Candidates, 2 Middlemen Arrested; Probe Reveals Wider Racket - News18
MPSC Drug Inspector Exam Leak: 2 Candidates, 2 Middlemen Arrested; Probe Reveals Wider Racket News18…
AI-led drug discovery to create decade-long CDMO tailwind: Harini Dedhia - Business Standard
AI-led drug discovery to create decade-long CDMO tailwind: Harini Dedhia Business Standard…